Table 3.
133 amino acids that form one of the major pockets (Pocket 1) of RdRp | Key residues | ||||||
---|---|---|---|---|---|---|---|
ALA_34_A | VAL_166_A | TYR_217_A | THR_248_A | PRO_620_A | SER_709_A | LEU_775_A | ASP_36_A |
PHE_35_A | PRO_169_A | ASP_218_A | ARG_249_A | LYS_621_A | VAL_720_A | VAL_776_A | PHE_45_A |
ASP_36_A | ILE_171_A | PHE_219_A | TYR_455_A | ARG_624_A | LEU_723_A | ALA_777_A | VAL_128_A |
TYR_38_A | LEU_172_A | GLY_220_A | ARG_457_A | ALA_625_A | GLN_724_A | PHE_782_A | ARG_132_A |
PHE_45_A | VAL_174_A | ASP_221_A | TYR_458_A | PRO_627_A | LEU_727_A | SER_784_A | HIS_133_A |
MET_124_A | TYR_175_A | PHE_222_A | ASN_459_A | LEU_630_A | TYR_728_A | VAL_785_A | LEU_240_A |
ALA_125_A | ALA_176_A | PRO_232_A | LEU_460_A | MET_633_A | LEU_731_A | LEU_786_A | CYS_464_A |
LEU_127_A | LEU_178_A | VAL_233_A | PRO_461_A | ASN_695_A | TYR_732_A | TYR_787_A | ASP_465_A |
VAL_128_A | ARG_181_A | VAL_234_A | THR_462_A | ILE_696_A | ARG_733_A | TYR_788_A | GLN_468_A |
TYR_129_A | VAL_182_A | SER_236_A | MET_463_A | CYS_697_A | PHE_741_A | GLN_789_A | LEU_469_A |
ALA_130_A | THR_189_A | TYR_237_A | CYS_464_A | GLN_698_A | PHE_745_A | ASN_790_A | VAL_472_A |
LEU_131_A | PHE_192_A | TYR_238_A | ASP_465_A | ALA_699_A | TYR_748_A | ASN_791_A | CYS_697_A |
ARG_132_A | CYS_193_A | SER_239_A | GLN_468_A | VAL_700_A | LEU_749_A | VAL_792_A | VAL_700_A |
HIS_133_A | VAL_204_A | LEU_240_A | LEU_469_A | THR_701_A | HIS_752_A | THR_701_A | |
PHE_134_A | LEU_205_A | LEU_241_A | PHE_471_A | ALA_702_A | PHE_753_A | VAL_704_A | |
THR_141_A | THR_206_A | PRO_243_A | VAL_472_A | ASN_703_A | MET_755_A | ASN_705_A | |
LEU_142_A | LEU_207_A | ILE_244_A | VAL_475_A | VAL_704_A | ILE_757_A | LEU_708_A | |
ILE_145_A | ASP_208_A | LEU_245_A | TYR_479_A | ASN_705_A | ALA_762_A | TYR_732_A | |
LEU_146_A | ASN_209_A | THR_246_A | MET_615_A | LEU_707_A | VAL_764_A | TYR_788_A | |
PHE_165_A | TRP_216_A | LEU_247_A | TRP_617_A | LEU_708_A | TYR_770_A | GLN_789_A |
Residues in bold are the key residues that contribute to the formation of RdRp in complexes with carvedilol and its metabolites.